**Correction to**: *British Journal of Cancer* (2011) **104**, 948--956; doi:[10.1038/bjc.2011.54](/doifinder/10.1038/bjc.2011.54)

When published originally, earlier this year in Volume 104, the authors noticed a couple of errors in the Results section.

The first is in the subheading entitled 'Selection of peptide- and ET-specific T cells\'. In the second paragraph of this subsection, on page 951, the second sentence should read 'For example, of the T cells initially specifically selected with the CHM1^319^/HLA-A^\*^0201-multimer, 96 cell lines were grown and tested for specific IFN-γ release against CHM1^319^ peptide.\'

The legend of [Figure 4](#fig1){ref-type="fig"} should read 'Low granzyme B responses against HLA class I blocked A673 and HLA-A^\*^0201^+^ PBMC compared with unblocked A673.\'

The publishers and authors are now happy to correct these errors.

![Low granzyme B responses against HLA class I blocked A673 and HLA-A^\*^0201^+^ PBMC compared with unblocked A673. HLA class I blocking before granzyme B ELISpots caused reversion of specific recognition by CHM1^319^ or EZH2^666^ peptide specific CD8^+^ T cells at an effector to target (E/T) ratio of 5:1. Granzyme B release upon contact with irradiated OKT3-stimulated/unstimulated HLA-A^\*^0201^+^ PBMC remained low compared with unblocked A673 at the same E/T ratio. Asterisks indicate significance levels of A673 lysis compared with respective controls (two-tailed *t*-test, ^\*^*P*\<0.05; ^\*\*^*P*\<0.01).](bjc2011305f1){#fig1}
